HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wim J G Oyen Selected Research

DPC11870-11

5/2005Scintigraphic imaging of infectious foci with an 111In-LTB4 antagonist is based on in vivo labeling of granulocytes.
10/2004Scintigraphic detection of pulmonary aspergillosis in rabbits with a radiolabeled leukotriene b4 antagonist.
1/2004Imaging of experimental colitis with a radiolabeled leukotriene B4 antagonist.
7/2003A bivalent leukotriene B(4) antagonist for scintigraphic imaging of infectious foci.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wim J G Oyen Research Topics

Disease

134Neoplasms (Cancer)
01/2021 - 12/2002
33Neoplasm Metastasis (Metastasis)
08/2021 - 10/2003
28Renal Cell Carcinoma (Grawitz Tumor)
01/2020 - 08/2003
25Infections
01/2018 - 03/2002
20Colorectal Neoplasms (Colorectal Cancer)
01/2017 - 08/2004
18Prostatic Neoplasms (Prostate Cancer)
10/2022 - 06/2011
13Head and Neck Neoplasms (Head and Neck Cancer)
01/2019 - 09/2003
12Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 08/2004
12Melanoma (Melanoma, Malignant)
03/2016 - 01/2003
10Squamous Cell Carcinoma of Head and Neck
01/2017 - 09/2003
10Inflammation (Inflammations)
07/2014 - 07/2003
10Hypoxia (Hypoxemia)
10/2013 - 08/2006
8Abscess
09/2013 - 03/2002
7Thyroid Neoplasms (Thyroid Cancer)
01/2021 - 11/2006
7Breast Neoplasms (Breast Cancer)
01/2018 - 10/2010
6Carcinoma (Carcinomatosis)
02/2016 - 10/2004
6Peritoneal Neoplasms
02/2009 - 01/2006
5Rheumatoid Arthritis
01/2022 - 02/2003
5Endocarditis
01/2018 - 06/2003
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2017 - 05/2010
5Fever (Fevers)
06/2015 - 01/2007
5Reperfusion Injury
12/2009 - 01/2005
4Thyroid Nodule (Nodule, Thyroid)
08/2022 - 05/2006
4Lung Neoplasms (Lung Cancer)
01/2022 - 08/2011
4Ovarian Neoplasms (Ovarian Cancer)
12/2014 - 08/2007
4Neuroendocrine Tumors (Neuroendocrine Tumor)
01/2014 - 09/2007
4Communicable Diseases (Infectious Diseases)
09/2013 - 12/2005
4Non-Hodgkin Lymphoma (Lymphosarcoma)
12/2005 - 05/2003
3Disease Progression
01/2021 - 09/2005
3Q Fever (Fever, Q)
01/2018 - 06/2003
3Bacteremia
01/2017 - 08/2010
3Cardiotoxicity
11/2015 - 04/2011
3Necrosis
04/2014 - 04/2011
3Lymphatic Metastasis
12/2013 - 07/2006
3Osteomyelitis
09/2013 - 03/2007

Drug/Important Bio-Agent (IBA)

34Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2022 - 01/2004
29Monoclonal AntibodiesIBA
01/2019 - 02/2003
28Peptides (Polypeptides)IBA
01/2018 - 12/2002
22AntigensIBA
10/2022 - 01/2003
21AntibodiesIBA
01/2017 - 03/2003
16Radioisotopes (Radionuclides)IBA
01/2021 - 08/2003
14RadiopharmaceuticalsIBA
08/2021 - 10/2004
14Carbonic Anhydrase IXIBA
01/2020 - 06/2006
13Proteins (Proteins, Gene)FDA Link
05/2015 - 10/2003
12G250 monoclonal antibodyIBA
01/2020 - 09/2003
12Glucose (Dextrose)FDA LinkGeneric
01/2017 - 08/2004
10Somatostatin Receptors (Somatostatin Receptor)IBA
11/2017 - 03/2006
9Biomarkers (Surrogate Marker)IBA
08/2021 - 11/2011
81,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021 - 11/2006
8Bevacizumab (Avastin)FDA Link
01/2017 - 09/2008
8Pentetic Acid (DTPA)FDA LinkGeneric
08/2015 - 09/2003
7Biological ProductsIBA
10/2015 - 01/2007
6Peptide Receptors (Peptide Receptor)IBA
01/2021 - 03/2006
6Anti-Bacterial Agents (Antibiotics)IBA
01/2015 - 06/2003
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2014 - 05/2008
5alovudineIBA
01/2017 - 05/2007
5VaccinesIBA
03/2016 - 04/2009
5Neoplasm Antigens (Tumor Antigens)IBA
03/2016 - 10/2003
5Insulin-Like PeptidesIBA
01/2015 - 12/2011
5fluoromisonidazoleIBA
10/2013 - 08/2006
5teprotumumabIBA
09/2013 - 10/2010
5Carcinoembryonic AntigenIBA
11/2010 - 07/2004
5Leukotriene B4IBA
08/2007 - 01/2004
5Interleukin-8 (Interleukin 8)IBA
03/2007 - 03/2002
4Radium-223IBA
07/2022 - 01/2017
4Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2021 - 03/2006
4Cetuximab (Erbitux)FDA Link
01/2019 - 08/2011
4ErbB Receptors (EGF Receptor)IBA
01/2019 - 06/2009
4Fluorine-18IBA
12/2018 - 01/2004
4HaptensIBA
02/2015 - 03/2003
4DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA
02/2015 - 04/2010
4Sorafenib (BAY 43-9006)FDA Link
11/2014 - 11/2010
4Cholecystokinin B ReceptorIBA
04/2011 - 11/2006
4pimonidazoleIBA
07/2010 - 10/2005
4AcidsIBA
02/2010 - 09/2003
4Integrin beta3 (GPIIIa)IBA
10/2009 - 11/2006
4Adenosine (Adenocard)FDA LinkGeneric
06/2009 - 01/2005
4DPC11870-11IBA
05/2005 - 07/2003
3Deoxyglucose (2 Deoxy D glucose)IBA
08/2022 - 10/2004
3IntegrinsIBA
01/2018 - 05/2013
3Therapeutic UsesIBA
01/2017 - 09/2003
3Monophenol Monooxygenase (Tyrosinase)IBA
03/2016 - 04/2009
3LutetiumIBA
01/2016 - 09/2013
3Indium-111IBA
05/2014 - 04/2009
3Oxygen (Dioxygen)IBA
10/2013 - 10/2005

Therapy/Procedure

60Therapeutics
10/2022 - 02/2003
33Radiotherapy
01/2019 - 12/2005
33Radioimmunotherapy
01/2016 - 03/2003
18Drug Therapy (Chemotherapy)
01/2017 - 02/2006
8Immunotherapy
03/2016 - 08/2003
7Laparotomy
04/2012 - 11/2006
5Castration
07/2022 - 12/2016
5Aftercare (After-Treatment)
01/2017 - 10/2006
5Gamma Cameras (Gamma Camera)
04/2009 - 03/2002
5Cytoreduction Surgical Procedures
06/2008 - 02/2006
4Blood Vessel Prosthesis
01/2018 - 12/2010
4Chemoradiotherapy
12/2016 - 04/2013
4Neoadjuvant Therapy
01/2015 - 11/2010
4Intravenous Administration
02/2011 - 07/2004
3Precision Medicine
01/2021 - 12/2018